Avistone Pharmaceuticals
鞍石生物
Avistone Pharmaceuticals
Biotech/Healthcare
Avistone Pharmaceuticals focuses on developing innovative oncology drugs and has a broad pipeline spanning lung cancer, glioma, and other tumor indications. Its c-Met-targeted drug candidate is in late-stage clinical development and received Breakthrough Therapy Designation from China's drug…
Latest round: Series B (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.